QT
INSY

Quantbot Technologies’s Insys Therapeutics, Inc. INSY Stock Holding History

Quantbot Technologies’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,946
Closed -$24K – 1541
2017
Q2 		$24K Sell
1,946
-4,588
-70% -$54.3K ﹤0.01% 990
2017
Q1 		$68K Buy
+6,534
New +$69.6K 0.01% 866
2016
Q2 		– Sell
-1,884
Closed -$30K – 1497
2016
Q1 		$30K Sell
1,884
-1,636
-46% -$31.1K ﹤0.01% 956
2015
Q4 		$100K Sell
3,520
-3,012
-46% -$83.4K 0.02% 647
2015
Q3 		$185K Buy
6,532
+4,632
+244% +$170K 0.03% 550
2015
Q2 		$68K Buy
+1,900
New +$59.2K 0.01% 757
2015
Q1 		– Sell
-3,502
Closed -$73K – 1482
2014
Q4 		$73K Buy
+3,502
New +$69.2K 0.02% 743
2014
Q3 		– Sell
-3,200
Closed -$49K – 1522
2014
Q2 		$49K Buy
+3,200
New +$51.7K 0.01% 940

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quantbot Technologies's INSY Position: Q3 2017 in Review

Quantbot Technologies sold out of Insys Therapeutics, Inc. (INSY) in Q3 2017, closing a stake of 1,946 shares — an estimated $24K sold.

Quantbot Technologies first reported a position in INSY in Q2 2014 and held it in 8 quarters. The position peaked at $185K in Q3 2015. 116 funds tracked by Wall St. Rank hold INSY as of Q3 2017.

  • Quantbot Technologies reported no remaining Insys Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
  • Quantbot Technologies sold 1,946 Insys Therapeutics, Inc. shares in Q3 2017, an estimated $24K.
  • Quantbot Technologies first reported a position in Insys Therapeutics, Inc. in Q2 2014 and held it in 8 quarters.
  • Quantbot Technologies's Insys Therapeutics, Inc. position peaked at $185K in Q3 2015.
  • 116 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2017.

Based on Quantbot Technologies's 13F filing for Q3 2017, filed 7 Nov 2017.